Oncimmune Holdings plc (LON:ONC – Get Free Report)’s stock price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 14.40 ($0.18) and traded as low as GBX 11.80 ($0.15). Oncimmune shares last traded at GBX 11.80 ($0.15), with a volume of 98,621 shares changing hands.
Oncimmune Trading Down 5.6 %
The stock has a 50-day moving average price of GBX 14.40 and a 200-day moving average price of GBX 14.80. The stock has a market cap of £8.75 million, a P/E ratio of -393.33 and a beta of 1.19. The company has a debt-to-equity ratio of 806.85, a quick ratio of 0.63 and a current ratio of 1.13.
Oncimmune Company Profile
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Read More
- Five stocks we like better than Oncimmune
- Investing in Travel Stocks Benefits
- MP Materials: Rare Earth Elements Powering the EV Boom
- How to Calculate Options Profits
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- How to Find Undervalued Stocks
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.